Cite
HARVARD Citation
Marchesi, F. et al. (2018). Lenograstim 5 µg/kg is not superior to biosimilar filgrastim 10 µg/kg in lymphoma patients undergoing peripheral blood stem cell mobilization after chemotherapy: preliminary results from a prospective randomized study. Transfusion. 58 (5), pp. 1143-1148. [Online].